# A Safety Study of ARRY-502 in Healthy Subjects

> **NCT01349725** · PHASE1 · COMPLETED · sponsor: **Array Biopharma, now a wholly owned subsidiary of Pfizer** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ARRY-502
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01349725
- **Lead sponsor:** Array Biopharma, now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01349725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01349725, "A Safety Study of ARRY-502 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01349725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*